Gene-based burden tests of rare germline variants identify six cancer susceptibility genes

• Published in: Nature genetics Vol. 56; no. 11; pp. 2422 - 2433
• Main Authors: Ivarsdottir, Erna V., Gudmundsson, Julius, Tragante, Vinicius, Sveinbjornsson, Gardar, Kristmundsdottir, Snaedis, Stacey, Simon N., Halldorsson, Gisli H., Magnusson, Magnus I., Oddsson, Asmundur, Walters, G. Bragi, Sigurdsson, Asgeir, Saevarsdottir, Saedis, Beyter, Doruk, Thorleifsson, Gudmar, Halldorsson, Bjarni V., Melsted, Pall, Stefansson, Hreinn, Jonsdottir, Ingileif, Sørensen, Erik, Pedersen, Ole B., Erikstrup, Christian, Bøgsted, Martin, Pøhl, Mette, Røder, Andreas, Stroomberg, Hein Vincent, Gögenur, Ismail, Hillingsø, Jens, Bojesen, Stig E., Lassen, Ulrik, Høgdall, Estrid, Ullum, Henrik, Brunak, Søren, Ostrowski, Sisse R., Sonderby, Ida Elken, Frei, Oleksandr, Djurovic, Srdjan, Havdahl, Alexandra, Moller, Pal, Dominguez-Valentin, Mev, Haavik, Jan, Andreassen, Ole A., Hovig, Eivind, Agnarsson, Bjarni A., Hilmarsson, Rafn, Johannsson, Oskar Th, Valdimarsson, Trausti, Jonsson, Steinn, Moller, Pall H., Olafsson, Jon H., Sigurgeirsson, Bardur, Jonasson, Jon G., Tryggvason, Geir, Holm, Hilma, Sulem, Patrick, Rafnar, Thorunn, Gudbjartsson, Daniel F., Stefansson, Kari
• Format: Journal Article
• Language: English
• Published: New York Nature Publishing Group US 01.11.2024
• Subjects: 38/23; 38/91; 631/208/205; 631/67; Agriculture; Animal Genetics and Genomics; Autophagy - genetics; Biomedical and Life Sciences; Biomedicine; Cancer Research; Case-Control Studies; Female; Gene Function; Genetic Predisposition to Disease; Germ-Line Mutation; Human Genetics; Humans; Iceland; Male; Neoplasms - genetics; Norway; United Kingdom - epidemiology; Norway; United Kingdom; Iceland
• ISSN: 1061-4036; 1546-1718; 1546-1718
• DOI: 10.1038/s41588-024-01966-6

Discovery of cancer risk variants in the sequence of the germline genome can shed light on carcinogenesis. Here we describe gene burden association analyses, aggregating rare missense and loss of function variants, at 22 cancer sites, including 130,991 cancer cases and 733,486 controls from Iceland, Norway and the United Kingdom. We identified four genes associated with increased cancer risk; the pro-apoptotic BIK for prostate cancer, the autophagy involved ATG12 for colorectal cancer, TG for thyroid cancer and CMTR2 for both lung cancer and cutaneous melanoma. Further, we found genes with rare variants that associate with decreased risk of cancer; AURKB for any cancer, irrespective of site, and PPP1R15A for breast cancer, suggesting that inhibition of PPP1R15A may be a preventive strategy for breast cancer. Our findings pinpoint several new cancer risk genes and emphasize autophagy, apoptosis and cell stress response as a focus point for developing new therapeutics. Burden testing in three large European ancestry cohorts identifies new risk genes for a number of common cancer types, including pan-cancer protective variants in AURKB and breast cancer protective variants in PPP1R15A.